罗氏诊断的人工智能应用 - Emerj人工智能研究
Artificial Intelligence at Roche Diagnostics - Emerj Artificial Intelligence Research
#Artificial Intelligence#Intelligence Research#Roche Diagnostics#Emerj Artificial#Research Artificial
生命科学资讯
生物技术与制药领域的最新动态
10x Genomics股价创52周新高，达17.26美元 - Investing.com报道
10x Genomics stock hits 52-week high at 17.26 USD - Investing.com
#Genomics stock#USD Investing.com#stock hits#Genomics#USD
罗氏报告BTK抑制剂在多发性硬化症三期试验中取得突破，成功超越竞争对手——Fierce Biotech报道
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech
#BTK inhibitor#Fierce Biotech#reports phase#multiple sclerosis#Roche reports
罗氏推出新药，或将颠覆整个多发性硬化症市场——雅虎财经报道
Roche Just Unleashed a Drug That Could Disrupt the Entire MS Market - Yahoo Finance
#Yahoo Finance#Market Yahoo#Finance Roche#Unleashed#Drug
罗氏控股股价今日为何飙升——雅虎财经报道
Why Roche Holding Stock Popped Today - Yahoo Finance
#Roche Holding#Holding Stock#Stock Popped#Popped Today#Yahoo Finance
罗氏实验性多发性硬化药物在两项关键试验中一项达到主要目标——路透社
Roche's experimental MS drug hits main goal in one of two key trials - Reuters
#Roche experimental#drug hits#hits main#main goal#key trials
罗氏多发性硬化症片剂在后期研究中取得成效——BioPharma Dive
Roche’s MS tablet scores in late-stage studies - BioPharma Dive
#BioPharma Dive#tablet scores#Dive Roche#late-stage studies#Dive
罗氏竞争对手因多发性硬化症治疗“史无前例”结果股价暴跌——投资者商业日报
Roche Rival Plunges On 'Unprecedented' Results In MS Treatment - Investor's Business Daily
#Rival Plunges#Investor Business#Business Daily#Roche Rival#Treatment Investor
Illumina (ILMN)：股价近期反弹后的估值探讨 - 雅虎财经
Illumina (ILMN): Exploring Valuation Following Recent Share Price Rebound - Yahoo Finance
#Exploring Valuation#Recent Share#Share Price#Price Rebound#Yahoo Finance
沃特世公司：增长机遇与挑战并存，维持持有评级——TipRanks
Waters Corporation: Balancing Growth Opportunities and Challenges with a Hold Rating - TipRanks
#Balancing Growth#Growth Opportunities#Waters Corporation#Hold Rating#Corporation
Thermo Fisher Scientific (TMO)：50亿美元股票回购计划后估值评估 - simplywall.st
Thermo Fisher Scientific (TMO): Evaluating Valuation After $5 Billion Share Buyback Announcement - simplywall.st
#Fisher Scientific#Evaluating Valuation#Billion Share#Share Buyback#Buyback Announcement
Illumina公司（纳斯达克：ILMN）股价飙升30%，投资者悲观情绪低于预期——SimplyWall.st
Illumina, Inc. (NASDAQ:ILMN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected - simplywall.st
#Stock Rockets#NASDAQ#ILMN#Stock#Rockets
安捷伦科技（NYSE:A）或可轻松承担更多债务 - 雅虎财经
Agilent Technologies (NYSE:A) Could Easily Take On More Debt - Yahoo Finance
#Agilent Technologies#Yahoo Finance#Debt Yahoo#NYSE#Finance Agilent
10x Genomics公司（纳斯达克代码：TXG）2025年第三季度财报电话会议记录 - 内幕猴子
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript - Insider Monkey
#Earnings Call#Genomics#Insider Monkey#Call Transcript#NASDAQ
10x Genomics (TXG) 四季度展望：需求转变还是产品创新显成效？- 雅虎财经
Does 10x Genomics' (TXG) Q4 Outlook Signal Shifting Demand or Product Innovation Taking Hold? - Yahoo Finance
#Outlook Signal#Taking Hold#Signal Shifting#Shifting Demand#Product Innovation
巴克莱维持对10x Genomics (TXG) 的超配评级 - 纳斯达克
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
#Overweight Recommendation#Barclays Maintains#Recommendation Nasdaq#Genomics#TXG
摩根大通维持对10x Genomics（TXG）的中性评级——纳斯达克
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
#Morgan Maintains#Neutral Recommendation#Recommendation Nasdaq#Genomics#TXG
10x Genomics (TXG) 股票今日为何上涨 - 雅虎财经
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
#Yahoo Finance#Today Yahoo#Genomics#TXG#Stock
监管、cGMP与CDMO挑战：CPHI与龙沙胶囊对话录（下篇）——PharmTech.com
Regulatory, cGMP, and CDMO Challenges: A CPHI Conversation with Lonza Capsugel, Part Two - PharmTech.com
#CDMO Challenges#Lonza Capsugel#CPHI Conversation#cGMP#Challenges
Illumina：卓越利润率与基因组测序市场将释放价值 - 寻求阿尔法
Illumina: An Excellent Profit Margin And The Sequencing Genome Market Will Unlock Value - Seeking Alpha
#Excellent Profit#Profit Margin#Sequencing Genome#Genome Market#Seeking Alpha